The extraordinary effect of cabergoline on male sexual power: benefits and harms
Male sexual impotence can occur at any age. No one should be ashamed of these difficulties, since no one is immune from them, but boldly look the enemy in the eye. In addition, today many effective drugs are produced aimed at combating male impotence. This article is about the miracle drug cabergoline. Laboratory studies have shown its effectiveness in treating male problems.
Contents of the article:
What is anorgasmia
A small study found that a condition called anorgasmia, which prevents men from fully enjoying their sex lives, was cured in 70% of cases with regular use of the drug. At least 50 of the 72 men experienced improvement, with 26 of the 50 saying cabergoline completely restored them and returned them to normal life.
At the meeting of the American Urological Association, Tung-Chin Hsieh, MD, presented a paper. In it, he stated that cabergoline is an effective drug for the treatment of anorgasmia. At the same time, he emphasized that this topic requires further research to better understand the pathophysiology of this syndrome. In most cases, anorgasmia is psychological in nature, but it can also occur in the context of a prostate cancer experience or as a side effect of medications.
Read also: Men”s sexual fantasies: 7 of the very best
Some people say that every person only needs one thing. This is absolutely true, but there are very different variations. Men”s sexual fantasies -.
The driving force behind cabergoline research was the observation of levels of the hormone prolactin in the male body during the post-ejaculatory phase, which led to a decrease in the likelihood of ejaculation. First of all, cabergoline is designed to eliminate excess levels of prolactin, which prevents full ejaculation. Tung-Chin Hsieh and his colleagues suggested that this drug could treat men with anorgasmia. They then initiated an independent study.
How can you save half-living neurons?
Treatment effectiveness was determined by subjective assessment of the patient”s return to normal sexual function. Significant improvement was observed in 69% of patients, and 52% reported complete recovery and restoration of sexual function. The average age of patients was 63 years.
Side effects
Cabergoline helped many regain their sexual confidence and potency, but in return, patients experienced other unpleasant aspects. Regarding the future, it is important to emphasize that not a single patient reported serious side effects. About 65% of study participants reported tolerable headaches and dizziness. The drug is not recommended for patients with heart or vascular problems, as it stimulates the acute phase of the disease. Before starting to take this medication, it is recommended to consult a doctor.
